Project description
Dissecting the mechanism of foetal abortion in toxoplasmosis
Toxoplasmosis is an infection caused by the Toxoplasma gondii parasite. Despite it being a health hazard for both humans and livestock, the mechanism of vertical transmission from mother to foetus remains elusive. The EU-funded TOXOSHEEP project proposes to use a sheep animal model and investigate how the parasite reaches the placenta and induces inflammation that eventually causes foetal abortion. Insight into gene expression changes at the mother–foetus interface will help unveil important information on the T. gondii infection mechanism. Project findings will pave the way for the design of vaccines or drugs that block parasite transmission and improve the health of pregnant women and their foetuses.
Objective
Toxoplasma gondii is a major cause of abortion in humans and livestock, thereby producing a significant public health hazard and economic losses. Most of Toxoplasma’s virulence factors have been explored using mouse models; however, the murine immune response differs significantly from that of humans and farm animals. Despite Toxoplasma’s enormous economic and health implications, little is known about the factors that cause foetal mortality and vertical transmission in humans or livestock. The goal of this ambitious project is to close this gap in knowledge by studying the mechanisms involved in the early abortion during the acute phase of toxoplasmosis in a standardised animal model relevant for humans and livestock. We hypothesise that by using a pregnant sheep model, the molecular mechanisms underlying the parasite-induced inflammation associated with early abortions can be identified. To this end, we will first characterize the early infection dynamics, lesions, parasite burden and peripheral immune response in the dams. This will provide valuable information as to the initial immune response elicited by the parasite and how it reaches the placenta. Subsequently, we will investigate the local molecular mechanisms involved in the parasite-induced pathogenesis of early abortions by combining novel immunohistopathological and transcriptomic approaches in order to identify alterations of gene expression and biological pathways in the materno-foetal interface. The results derived from this proposal will significantly advance the understanding of the mechanisms of Toxoplasma early abortions and help in the design of transmission-blocking vaccines or drugs. Because Toxoplasma has been associated with women who had spontaneous abortions, it is likely that these mechanisms are shared with humans. Thus, these results will not only produce economic savings in the livestock industry but will also directly improve human health.
Fields of science (EuroSciVoc)
CORDIS classifies projects with EuroSciVoc, a multilingual taxonomy of fields of science, through a semi-automatic process based on NLP techniques. See: The European Science Vocabulary.
CORDIS classifies projects with EuroSciVoc, a multilingual taxonomy of fields of science, through a semi-automatic process based on NLP techniques. See: The European Science Vocabulary.
- medical and health sciences health sciences public health
- medical and health sciences basic medicine immunology
- medical and health sciences basic medicine pharmacology and pharmacy pharmaceutical drugs vaccines
- medical and health sciences clinical medicine obstetrics
- agricultural sciences animal and dairy science domestic animals animal husbandry
You need to log in or register to use this function
We are sorry... an unexpected error occurred during execution.
You need to be authenticated. Your session might have expired.
Thank you for your feedback. You will soon receive an email to confirm the submission. If you have selected to be notified about the reporting status, you will also be contacted when the reporting status will change.
Keywords
Project’s keywords as indicated by the project coordinator. Not to be confused with the EuroSciVoc taxonomy (Fields of science)
Project’s keywords as indicated by the project coordinator. Not to be confused with the EuroSciVoc taxonomy (Fields of science)
Programme(s)
Multi-annual funding programmes that define the EU’s priorities for research and innovation.
Multi-annual funding programmes that define the EU’s priorities for research and innovation.
-
H2020-EU.1.3. - EXCELLENT SCIENCE - Marie Skłodowska-Curie Actions
MAIN PROGRAMME
See all projects funded under this programme -
H2020-EU.1.3.2. - Nurturing excellence by means of cross-border and cross-sector mobility
See all projects funded under this programme
Topic(s)
Calls for proposals are divided into topics. A topic defines a specific subject or area for which applicants can submit proposals. The description of a topic comprises its specific scope and the expected impact of the funded project.
Calls for proposals are divided into topics. A topic defines a specific subject or area for which applicants can submit proposals. The description of a topic comprises its specific scope and the expected impact of the funded project.
Funding Scheme
Funding scheme (or “Type of Action”) inside a programme with common features. It specifies: the scope of what is funded; the reimbursement rate; specific evaluation criteria to qualify for funding; and the use of simplified forms of costs like lump sums.
Funding scheme (or “Type of Action”) inside a programme with common features. It specifies: the scope of what is funded; the reimbursement rate; specific evaluation criteria to qualify for funding; and the use of simplified forms of costs like lump sums.
MSCA-IF - Marie Skłodowska-Curie Individual Fellowships (IF)
See all projects funded under this funding scheme
Call for proposal
Procedure for inviting applicants to submit project proposals, with the aim of receiving EU funding.
Procedure for inviting applicants to submit project proposals, with the aim of receiving EU funding.
(opens in new window) H2020-MSCA-IF-2020
See all projects funded under this callCoordinator
Net EU financial contribution. The sum of money that the participant receives, deducted by the EU contribution to its linked third party. It considers the distribution of the EU financial contribution between direct beneficiaries of the project and other types of participants, like third-party participants.
28040 MADRID
Spain
The total costs incurred by this organisation to participate in the project, including direct and indirect costs. This amount is a subset of the overall project budget.